Drug-induced crystalluria attributable to tosufloxacin in children.
Yukari AtsumiHaruka YamanakaKatsuyoshi ShimozawaJunko YamanakaHideko UryuAyumi MizukamiHiroyuki ShichinoPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2022)
TFLX-induced crystalluria occurred despite administration of the appropriate dose of TFLX. Physicians should recognize crystalluria and renal injury attributable to TFLX. It may be possible to prevent renal injury by discontinuing drug therapy.